Forty percent of Palestinians are clinically depressed, a rate unmatched anywhere in the word. It’s more than triple that of the U.S., ten times higher than in the U.K., and four to eight times higher than in Scandinavia, where the sun doesn’t shine for a good part of the year. For Palestinian neuroscientist Mohammad Herzallah, this epidemic is an opportunity, if a tragic one, because it has made his country an ideal place to do groundbreaking research into the effects of depression on the brain.
Shared publicly